Recently added

Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients

Jiménez, Natalia; Garcia de Herreros, Marta; Reig Torras, Oscar; Marín-Aguilera, Mercedes; Aversa, Caterina; Ferrer-Mileo, Laura; CROS COSTA, SARA; Carles, Joan; Suárez, Cristina (Elsevier, 2024-03-01)

MYC targeting by OMO-103 in solid tumors: a phase 1 trial

Martínez Martín, Sandra; Alonso-Casal, Guzman; Arqués, Oriol; GARRALDA, Elena; Beaulieu, Marie-Eve; Casacuberta-Serra, Sílvia; Foradada Felip, Laia; Perez-Lopez, Raquel; Whitfield, Jonathan; Soucek, Laura; Moreno, Victor (Nature Portfolio, 2024-02-06)

An accessible deep learning tool for voxel-wise classification of brain malignancies from perfusion MRI

Garcia Ruiz, Alonso; Pons-Escoda, Albert; Naval-Baudin, Pablo; Monreal-Aguero, Camilo; Hermann, Gretchen; Grussu, Francesco; Ligero, Marta; Perez-Lopez, Raquel (Cell Press, 2024-03-19)

MYC: there is more to it than cancer

Zacarias Fluck, Mariano F; Soucek, Laura; Whitfield, Jonathan (Frontiers Media, 2024-03-06)

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial

Parikh, Aparna; Spigel, David; Cohn, Allen L.; Kochenderfer, Mark; Yoshino, Takayuki; Elez, Elena; Tabernero, Josep; Lenz, Heinz-Josef (BMJ, 2024-03-13)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

VHIO - Articles científics: Recent submissions

Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients

MYC targeting by OMO-103 in solid tumors: a phase 1 trial

An accessible deep learning tool for voxel-wise classification of brain malignancies from perfusion MRI

MYC: there is more to it than cancer

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial

Scientia. Dipòsit d'Informació Digital del Departament de Salut

VHIO - Articles científics: Recent submissions

Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients ﻿

MYC targeting by OMO-103 in solid tumors: a phase 1 trial ﻿

An accessible deep learning tool for voxel-wise classification of brain malignancies from perfusion MRI ﻿

MYC: there is more to it than cancer ﻿

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial ﻿

Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients

MYC targeting by OMO-103 in solid tumors: a phase 1 trial

An accessible deep learning tool for voxel-wise classification of brain malignancies from perfusion MRI

MYC: there is more to it than cancer

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial